|
1
|
Felson DT, Naimark A, Anderson J, Kazis L,
Castelli W and Meenan RF: The prevalence of knee osteoarthritis in
the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum.
30:914–918. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Oztürkmen Y, Uzümcügil O, Karamehmetoğlu
M, Leblebici C and Caniklioğlu M: Total knee arthroplasty for the
management of joint destruction in tuberculous arthritis. Knee Surg
Sports Traumatol Arthrosc. 22:1076–1083. 2014. View Article : Google Scholar
|
|
3
|
Spector TD and MacGregor AJ: Risk factors
for osteoarthritis: Genetics. Osteoarthritis and cartilage/OARS.
Osteoarthritis Res Soc. 12:S39–S44. 2004. View Article : Google Scholar
|
|
4
|
arcOGEN Consortium, arcOGEN Collaborators;
Zeggini E, Panoutsopoulou K, Southam L, Rayner NW, Day-Williams AG,
Lopes MC, Boraska V, Esko T, et al: Identification of new
susceptibility loci for osteoarthritis (arcOGEN): A genome-wide
association study. Lancet. 380:815–823. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Castaño Betancourt MC, Cailotto F, Kerkhof
HJ, Cornelis FM, Doherty SA, Hart DJ, Hofman A, Luyten FP,
Maciewicz RA, Mangino M, et al: Genome-wide association and
functional studies identify the DOT1L gene to be involved in
cartilage thickness and hip osteoarthritis. Proc Natl Acad Sci USA.
109:8218–8223. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bijsterbosch J, Kloppenburg M, Reijnierse
M, Rosendaal FR, Huizinga TW, Slagboom PE and Meulenbelt I:
Association study of candidate genes for the progression of hand
osteoarthritis. Osteoarthritis Cartilage. 21:565–569. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Grimaud E, Heymann D and Rédini F: Recent
advances in TGF-beta effects on chondrocyte metabolism. Potential
therapeutic roles of TGF-beta in cartilage disorders. Cytokine
Growth Factor Rev. 13:241–257. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tetlow LC, Adlam DJ and Woolley DE: Matrix
metalloproteinase and proinflammatory cytokine production by
chondrocytes of human osteoarthritic cartilage: Associations with
degenerative changes. Arthritis Rheum. 44:585–594. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Enochson L, Stenberg J, Brittberg M and
Lindahl A: GDF5 reduces MMP13 expression in human chondrocytes via
DKK1 mediated canonical Wnt signaling inhibition. Osteoarthritis
Cartilage. 22:566–577. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mikic B: Multiple effects of GDF-5
deficiency on skeletal tissues: Implications for therapeutic
bioengineering. Ann Biomed Eng. 32:466–476. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dodd AW, Syddall CM and Loughlin J: A rare
variant in the osteoarthritis-associated locus GDF5 is functional
and reveals a site that can be manipulated to modulate GDF5
expression. Eur J Hum Genet. 21:517–521. 2013. View Article : Google Scholar :
|
|
12
|
Kuo CK, Li WJ, Mauck RL and Tuan RS:
Cartilage tissue engineering: Its potential and uses. Curr Opin
Rheumatol. 18:64–73. 2006. View Article : Google Scholar
|
|
13
|
Kim YG, Cha J and Chandrasegaran S: Hybrid
restriction enzymes: Zinc finger fusions to Fok I cleavage domain.
Proc Natl Acad Sci USA. 93:1156–1160. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun N and Zhao H: Transcription
activator-like effector nucleases (TALENs): A highly efficient and
versatile tool for genome editing. Biotechnol Bioeng.
110:1811–1821. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang T, Wei JJ, Sabatini DM and Lander ES:
Genetic screens in human cells using the CRISPR-Cas9 system.
Science. 343:80–84. 2014. View Article : Google Scholar
|
|
16
|
Gao F, Shen XZ, Jiang F, Wu Y and Han C:
DNA-guided genome editing using the Natronobacterium gregoryi
Argonaute. Nat Biotechnol. 34:768–773. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pankowicz FP, Barzi M, Legras X, Hubert L,
Mi T, Tomolonis JA, Ravishankar M, Sun Q, Yang D, Borowiak M, et
al: Reprogramming metabolic pathways in vivo with CRISPR/Cas9
genome editing to treat hereditary tyrosinaemia. Nat Commun.
7:126422016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Katz AJ, Tholpady A, Tholpady SS, Shang H
and Ogle RC: Cell surface and transcriptional characterization of
human adipose-derived adherent stromal (hADAS) cells. Stem Cells.
23:412–423. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Doyle EL, Booher NJ, Standage DS, Voytas
DF, Brendel VP, Vandyk JK and Bogdanove AJ: TAL effector-nucleotide
targeter (TALE-NT) 2.0: Tools for TAL effector design and target
prediction. Nucleic Acids Res. 40:W117–W122. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cermak T, Doyle EL, Christian M, Wang L,
Zhang Y, Schmidt C, Baller JA, Somia NV, Bogdanove AJ and Voytas
DF: Efficient design and assembly of custom TALEN and other TAL
effector-based constructs for DNA targeting. Nucleic Acids Res.
39:e822011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Miller JC, Tan S, Qiao G, Barlow KA, Wang
J, Xia DF, Meng X, Paschon DE, Leung E, Hinkley SJ, et al: A TALE
nuclease architecture for efficient genome editing. Nat Biotechnol.
29:143–148. 2011. View Article : Google Scholar
|
|
22
|
Liew A, André FM, Lesueur LL, De Ménorval
MA, O'Brien T and Mir LM: Robust, efficient, and practical
electrogene transfer method for human mesenchymal stem cells using
square electric pulses. Hum Gene Ther Methods. 24:289–297. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sakurai T, Watanabe S, Kamiyoshi A, Sato M
and Shindo T: A single blastocyst assay optimized for detecting
CRISPR/Cas9 system-induced indel mutations in mice. BMC Biotechnol.
14:692014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ibrahim AM, Elgharabawi NM, Makhlouf MM
and Ibrahim OY: Chondrogenic differentiation of human umbilical
cord blood-derived mesenchymal stem cells in vitro. Microsc Res
Tech. 78:667–675. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Darzynkiewicz Z, Sharpless T,
Staiano-Coico L and Melamed MR: Subcompartments of the G1 phase of
cell cycle detected by flow cytometry. Proc Natl Acad Sci USA.
77:6696–6699. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Floris I, Billard H, Boquien CY,
Joram-Gauvard E, Simon L, Legrand A, Boscher C, Rozé JC,
Bolaños-Jiménez F and Kaeffer B: MiRNA analysis by quantitative PCR
in preterm human breast milk reveals daily fluctuations of
hsa-miR-16-5p. PLoS One. 10:e01404882015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Roszek K, Porowińska D, Bajek A, Hołysz M
and Czarnecka J: Chondrogenic differentiation of human mesenchymal
stem cells results in substantial changes of ecto-nucleotides
metabolism. J Cell Biochem. 116:2915–2923. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Héraud F, Héraud A and Harmand MF:
Apoptosis in normal and osteoarthritic human articular cartilage.
Ann Rheum Dis. 59:959–965. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hwang HS and Kim HA: Chondrocyte apoptosis
in the pathogenesis of osteoarthritis. Int J Mol Sci.
16:26035–26054. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Itoh S, Kanno S, Gai Z, Suemoto H,
Kawakatsu M, Tanishima H, Morimoto Y, Nishioka K, Hatamura I,
Yoshida M, et al: Trps1 plays a pivotal role downstream of Gdf5
signaling in promoting chondrogenesis and apoptosis of ATDC5 cells.
Genes Cells. 13:355–363. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Murphy G and Nagase H: Reappraising
metalloproteinases in rheumatoid arthritis and osteoarthritis:
Destruction or repair? Nat Clin Pract Rheumatol. 4:128–135. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Baragi VM, Becher G, Bendele AM, Biesinger
R, Bluhm H, Boer J, Deng H, Dodd R, Essers M, Feuerstein T, et al:
A new class of potent matrix metalloproteinase 13 inhibitors for
potential treatment of osteoarthritis: Evidence of histologic and
clinical efficacy without musculoskeletal toxicity in rat models.
Arthritis Rheum. 60:2008–2018. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Miyamoto Y, Mabuchi A, Shi D, Kubo T,
Takatori Y, Saito S, Fujioka M, Sudo A, Uchida A, Yamamoto S, et
al: A functional polymorphism in the 5′ UTR of GDF5 is associated
with susceptibility to osteoarthritis. Nat Genet. 39:529–533. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Reynard LN, Bui C, Syddall CM and Loughlin
J: CpG meth-ylation regulates allelic expression of GDF5 by
modulating binding of SP1 and SP3 repressor proteins to the
osteoarthritis susceptibility SNP rs143383. Hum Genet.
133:1059–1073. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ratnayake M, Plöger F, Santibanez-Koref M
and Loughlin J: Human chondrocytes respond discordantly to the
protein encoded by the osteoarthritis susceptibility gene GDF5.
PLoS One. 9:e865902014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Schuerwegh AJ, Van Offel JF, Stevens WJ,
Bridts CH and De Clerck LS: Influence of therapy with chimeric
monoclonal tumour necrosis factor-alpha antibodies on intracellular
cytokine profiles of T lymphocytes and monocytes in rheumatoid
arthritis patients. Rheumatology (Oxford). 42:541–548. 2003.
View Article : Google Scholar
|
|
37
|
Pettersen I, Figenschau Y, Olsen E,
Bakkelund W, Smedsröd B and Sveinbjörnsson B: Tumor necrosis
factor-related apop-tosis-inducing ligand induces apoptosis in
human articular chondrocytes in vitro. Biochem Biophys Res Commun.
296:671–676. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: Components, mechanisms, and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Thomas E, Peat G and Croft P: Defining and
mapping the person with osteoarthritis for population studies and
public health. Rheumatology (Oxford). 53:338–345. 2014. View Article : Google Scholar
|
|
40
|
Sarzi-Puttini P, Cimmino MA, Scarpa R,
Caporali R, Parazzini F, Zaninelli A, Atzeni F and Canesi B:
Osteoarthritis: An overview of the disease and its treatment
strategies. Semin Arthritis Rheum. 35(Suppl 1): 1–10. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Goldring MB: The role of the chondrocyte
in osteoarthritis. Arthritis Rheum. 43:1916–1926. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Visweswaran M, Pohl S, Arfuso F, Newsholme
P, Dilley R, Pervaiz S and Dharmarajan A: Multi-lineage
differentiation of mesenchymal stem cells - To Wnt, or not Wnt. Int
J Biochem Cell Biol. 68:139–147. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gimble JM, Katz AJ and Bunnell BA:
Adipose-derived stem cells for regenerative medicine. Circ Res.
100:1249–1260. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kraus VB, Jordan JM, Doherty M, Wilson AG,
Moskowitz R, Hochberg M, Loeser R, Hooper M, Renner JB, Crane MM,
et al: The Genetics of Generalized Osteoarthritis (GOGO) study:
Study design and evaluation of osteoarthritis phenotypes.
Osteoarthritis Cartilage. 15:120–127. 2007. View Article : Google Scholar
|
|
45
|
Tsezou A: Osteoarthritis year in review
2014: Genetics and genomics. Osteoarthritis Cartilage.
22:2017–2024. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hendel A, Fine EJ, Bao G and Porteus MH:
Quantifying on- and off-target genome editing. Trends Biotechnol.
33:132–140. 2015. View Article : Google Scholar : PubMed/NCBI
|
